Baxter recalls clindamycin, vasopressin, daptomycin and Cardene IV injections over manufacturing rule violations
The notice says these four Baxter premixed injection products were made with deviations from current good manufacturing practice, and it does not describe a specific defect or health risk.
What to do
The notice does not give instructions. Read the official notice for details.
Recall details
- Product
- Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.; Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012…
- Hazard
- CGMP Deviations
- Units
- N/A
- Where sold
- US Nationwide; Puerto Rico; and Chile.
- FDA classification
- Class II · Ongoing
- Classified by FDA
- August 28, 2026
- Recall started
- August 6, 2026
- FDA enforcement report
- September 9, 2026
- Identifiers
- Codes: Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027.
- FDA recall number: D-0815-2026
- Codes: Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028.
- FDA recall number: D-0811-2026
- Codes: Lot # NC193856, Exp Date: 04/18/2028.
- FDA recall number: D-0821-2026
- Codes: Lot # NC177818, Exp Date: 12/31/2026; Lot # NC188869, Exp Date: 12/31/2027.
- FDA recall number: D-0813-2026
- Codes: Lot # NC194129, Exp Date: 05/07/2028.
- FDA recall number: D-0812-2026
- Codes: Lot # NC188692, Exp Date: 11/22/2027.
- FDA recall number: D-0807-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50. | Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12. | Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12. | CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.
- Reason for recall
- CGMP Deviations
- Classification
- Class II (Ongoing)
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Quantity
- N/A
Related recalls
Baxter recalls Cefazolin in Dextrose 2g/100mL frozen infusion bags over particles found in the product
The recalled frozen premixed cefazolin infusion bags may contain particulate matter, which means small foreign particles could be present in the medicine.
Baxter Healthcare Corporation · 19,032 bags